Insights

Market Expansion Eurofins CALIXAR’s recent acquisition by Eurofins Discovery and introduction of new distribution channels through partnerships with CliniSciences, BioD, and AFS BioOil indicates an expanding global footprint and increasing market penetration. This presents opportunities to offer tailored membrane protein solutions to a broader customer base across different regions.

Innovative Platform The company's specialized technology for high-purity native membrane protein isolation, particularly for critical drug targets like GPCRs and ion channels, makes it a valuable partner for pharmaceutical firms involved in structure-based drug design, high throughput screening, and vaccine development. Selling high-value, custom solutions to these segments could accelerate drug discovery efforts.

Research Collaborations Active collaborations with academic institutions and pharma companies, highlighted by publications in high-impact journals like Cell Reports, suggest opportunities to develop joint R&D projects, licensing agreements, or custom services for clients seeking advanced structural biology tools and platforms.

Growing Industry Need With membrane proteins constituting over 60% of therapeutic targets, CALIXAR’s focus on native conformation preservation positions it well to serve biotech and pharma companies aiming to develop more effective drugs and vaccines, addressing the increasing demand for high-quality biological tools in drug development pipelines.

Financial Opportunities Despite a modest revenue range, the company’s strategic investments and unique technology platform suggest potential for upselling premium services such as crystallization, structural analysis, and custom target development, especially as the biotech industry continues to prioritize membrane protein-based therapeutics.

Eurofins CALIXAR Tech Stack

Eurofins CALIXAR uses 8 technology products and services including LiteSpeed Cache, WordPress, Swiper, and more. Explore Eurofins CALIXAR's tech stack below.

  • LiteSpeed Cache
    Caching
  • WordPress
    Content Management System
  • Swiper
    Javascript Libraries
  • HubSpot
    Marketing Automation
  • Webflow
    Page Builders
  • HSTS
    Security
  • Google Tag Manager
    Tag Management
  • HTTP/3
    Web & Portal Technology

Eurofins CALIXAR's Email Address Formats

Eurofins CALIXAR uses at least 1 format(s):
Eurofins CALIXAR Email FormatsExamplePercentage
FLast@calixar.comJDoe@calixar.com
47%
LastFir@calixar.comDoeJoh@calixar.com
3%
FLast@calixar.comJDoe@calixar.com
47%
LastFir@calixar.comDoeJoh@calixar.com
3%

Frequently Asked Questions

Where is Eurofins CALIXAR's headquarters located?

Minus sign iconPlus sign icon
Eurofins CALIXAR's main headquarters is located at 60 AVENUE ROCKEFELLER, LYON, 69008, FR. The company has employees across 1 continents, including Europe.

What is Eurofins CALIXAR's phone number?

Minus sign iconPlus sign icon
You can contact Eurofins CALIXAR's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Eurofins CALIXAR's official website and social media links?

Minus sign iconPlus sign icon
Eurofins CALIXAR's official website is calixar.com and has social profiles on LinkedInCrunchbase.

What is Eurofins CALIXAR's SIC code NAICS code?

Minus sign iconPlus sign icon
Eurofins CALIXAR's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Eurofins CALIXAR have currently?

Minus sign iconPlus sign icon
As of October 2025, Eurofins CALIXAR has approximately 13 employees across 1 continents, including Europe. Key team members include Co-Founder Of The Calixar Company: P. F.Marketing Director, Europe: G. D.Scientific Director: K. K.. Explore Eurofins CALIXAR's employee directory with LeadIQ.

What industry does Eurofins CALIXAR belong to?

Minus sign iconPlus sign icon
Eurofins CALIXAR operates in the Biotechnology Research industry.

What technology does Eurofins CALIXAR use?

Minus sign iconPlus sign icon
Eurofins CALIXAR's tech stack includes LiteSpeed CacheWordPressSwiperHubSpotWebflowHSTSGoogle Tag ManagerHTTP/3.

What is Eurofins CALIXAR's email format?

Minus sign iconPlus sign icon
Eurofins CALIXAR's email format typically follows the pattern of FLast@calixar.com. Find more Eurofins CALIXAR email formats with LeadIQ.

How much funding has Eurofins CALIXAR raised to date?

Minus sign iconPlus sign icon
As of October 2025, Eurofins CALIXAR has raised $1.1M in funding. The last funding round occurred on Feb 24, 2015 for $1.1M.

When was Eurofins CALIXAR founded?

Minus sign iconPlus sign icon
Eurofins CALIXAR was founded in 2011.

Eurofins CALIXAR

Biotechnology ResearchFrance11-50 Employees

To contact us : contact@calixar.com
CALIXAR, is a biotech company specialized in the functional and native isolation of complex membrane therapeutic targets and antigens.
We develop and implement chemistry and biochemistry tools to isolate in solution - with the highest purity levels - full-length membrane proteins, while keeping their structural and functional integrity. Our approach represents the opportunity for pharmaceutical companies to start and work with high quality targets or antigens before developing antibodies, formulating vaccines and/or discovering a primary lead through Structure Based Drug Design or High Throughput Screening assays.
As membrane proteins represent more than 60% of pharmaceutical drug targets, to keep their native conformation during the extraction from membrane cells and solubilization is crucial.
Our technological platform preserves the original structure of membrane proteins  such as GPCRs, Ion channels, Transporters, Viral targets,  etc.) or others native receptors acting as drug targets or antigens. As a result, this most accurate targeting helps biotechs, academic teams, pharmaceutical industries to develop highly potential drugs, bio drugs and vaccines and consequently saves significant time and money in further clinical stages.
By using original chemistry and specific approaches designed on demand, we develop new tools and protocols for the identification, expression, extraction, purification and crystallization of these membrane proteins/antigens from cells or from endogenous materials (virus, bacteria, primary cells, organs, etc.).
For SBDD/FBDD approaches, we carry out crystallization tests and structure determination of these native targets starting from their full-length and functional version without any point mutations or deletions.
CALIXAR sets up specific R&D programs with its customers using classical and flexible business model: Fee for service, Risk sharing, Exclusivity option and Licensing out.

Section iconCompany Overview

Headquarters
60 AVENUE ROCKEFELLER, LYON, 69008, FR
Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2011
Employees
11-50

Section iconFunding & Financials

  • $1.1M

    Eurofins CALIXAR has raised a total of $1.1M of funding over 2 rounds. Their latest funding round was raised on Feb 24, 2015 in the amount of $1.1M.

  • $1M

    Eurofins CALIXAR's revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $1.1M

    Eurofins CALIXAR has raised a total of $1.1M of funding over 2 rounds. Their latest funding round was raised on Feb 24, 2015 in the amount of $1.1M.

  • $1M

    Eurofins CALIXAR's revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.